Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Conferences

ecancer travels so that you don't have to. Explore the latest conference coverage in global oncology and find out where we are going next.
Recent
Upcoming
Share :

SABCS 2018

4 - 8 Dec 2018
Henry B. Gonzalez, San Antonio, United States of America
Videos
News
Regional radiation benefits high risk breast cancer patients
Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK
Regional radiation benefits high risk breast cancer patients ( Prof David Dodwell - Nuffield Department of Population Health, Oxford, UK )
14 Dec 2018
Axillary dissection in clinically node negative breast cancer patients...
Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA
Axillary dissection in clinically node negative breast cancer patients undergoing breast conserving surgery ( Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA )
14 Dec 2018
Practical approach to the management of the axilla after neoadjuvant...
Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA
Practical approach to the management of the axilla after neoadjuvant chemotherapy ( Dr Andrea Barrio - Memorial Sloan Kettering Cancer Centre, New York, USA )
14 Dec 2018
Modern methods of phase 1 clinical trial design
Prof Susan Hilsenbeck - Baylor College of Medicine, Houston, USA
Modern methods of phase 1 clinical trial design ( Prof Susan Hilsenbeck - Baylor College of Medicine, Houston, USA )
14 Dec 2018
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from...
Dr Dejan Juric - Massachusetts General Hospital, Boston, USA
Alpelisib plus fulvestrant for advanced breast cancer: Subgroup analyses from the phase III SOLAR-1 trial ( Dr Dejan Juric - Massachusetts General Hospital, Boston, USA )
14 Dec 2018
Polygenic risk scores for breast cancer: ready or not?
Prof Gareth Evans - University of Manchester, Manchester, UK
Polygenic risk scores for breast cancer: ready or not? ( Prof Gareth Evans - University of Manchester, Manchester, UK )
14 Dec 2018
Modulation of anti-tumour immunity using CDK4/6 inhibitors
Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA
Modulation of anti-tumour immunity using CDK4/6 inhibitors ( Dr Shom Goel - Dana-Farber Cancer Institute, Boston, USA )
14 Dec 2018
Brain metastases developed from HER2 positive and triple negative breast cancer
Dr Patricia Steeg - National Cancer Institute, Bethesda, USA
Brain metastases developed from HER2 positive and triple negative breast cancer ( Dr Patricia Steeg - National Cancer Institute, Bethesda, USA )
14 Dec 2018
Single cell genomics in breast cancer: breast tumour evolution and intra-tumour...
Dr Nicholas Navin - MD Anderson Cancer Center, Houston, USA
Single cell genomics in breast cancer: breast tumour evolution and intra-tumour heterogeneity ( Dr Nicholas Navin - MD Anderson Cancer Center, Houston, USA )
14 Dec 2018
Chemo-immuno combination shows improved PFS when compared with sole...
Prof Leisha Emens - Johns Hopkins Kimmel Cancer, Baltimore, USA
Chemo-immuno combination shows improved PFS when compared with sole chemotherapy treatment in advanced breast cancer ( Prof Leisha Emens - Johns Hopkins Kimmel Cancer, Baltimore, USA )
14 Dec 2018
Association of pathologic complete response following neoadjuvant chemotherapy...
Dr Laura Spring - Harvard Medical School, Boston, USA
Association of pathologic complete response following neoadjuvant chemotherapy with longterm survival in breast cancer ( Dr Laura Spring - Harvard Medical School, Boston, USA )
14 Dec 2018
Results from adding adjuvant capecitabine to treatment for breast cancer...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
Results from adding adjuvant capecitabine to treatment for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )
13 Dec 2018
SABCS 2018: Highlights in breast cancer treatment
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2018: Highlights in breast cancer treatment ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
13 Dec 2018
Prognostic value of circulating tumour-cell count in metastatic breast cancer...
Dr Francois-Clement Bidard - Institut Curie, Paris, France
Prognostic value of circulating tumour-cell count in metastatic breast cancer patients ( Dr Francois-Clement Bidard - Institut Curie, Paris, France )
13 Dec 2018
Accelerated partial breast Irradiation vs whole breast irradiation to control...
Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA
Accelerated partial breast Irradiation vs whole breast irradiation to control ipsilateral breast tumour recurrence ( Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA )
13 Dec 2018
Low-dose tamoxifen as effective as higher doses for breast cancer patients
Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy
Low-dose tamoxifen as effective as higher doses for breast cancer patients ( Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy )
13 Dec 2018
Radiotherapy or surgery of the axilla after a positive sentinel node in breast...
Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands
Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients ( Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands )
13 Dec 2018
Improved IDFS for breast cancer patients who received trastuzumab emtansine
Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA
Improved IDFS for breast cancer patients who received trastuzumab emtansine ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )
13 Dec 2018
Accelerated partial breast irradiation not equivalent to whole breast...
Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA
Accelerated partial breast irradiation not equivalent to whole breast irradiation ( Dr Frank Vicini - St Joseph Mercy Oakland, Pontiac, USA )
12 Dec 2018
Circulating tumour-cell count used to decide between treatments for breast...
Dr Francois-Clement Bidard - Institut Curie, Paris, France
Circulating tumour-cell count used to decide between treatments for breast cancer patients ( Dr Francois-Clement Bidard - Institut Curie, Paris, France )
12 Dec 2018
Axillary radiotherapy and surgery show comparable long term outcomes for...
Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands
Axillary radiotherapy and surgery show comparable long term outcomes for patients with breast cancer ( Prof Emiel Rutgers - Netherlands Cancer Institute Amsterdam, Netherlands )
12 Dec 2018
Low-dose tamoxifen reduces recurrence and new breast disease
Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy
Low-dose tamoxifen reduces recurrence and new breast disease ( Prof Andrea De Censi - S.C. Oncologia Medica, Genoa, Italy )
12 Dec 2018
Adjuvant capecitabine did not significantly improve outcomes for breast cancer...
Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain
Adjuvant capecitabine did not significantly improve outcomes for breast cancer patients ( Dr Miguel Martín - Universidad Complutense de Madrid, Madrid, Spain )
12 Dec 2018
Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for...
Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA
Substituting trastuzumab emtansine for adjuvant trastuzumab improved IDFS for breast cancer patients ( Prof Charles Geyer - Allegheny General Hospital, Pittsburgh, USA )
12 Dec 2018
Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients
Professors Hope Rugo, Debu Tripathy, Nadia Harbeck and Dr Steven Isakoff
Scalp cooling to prevent chemotherapy induced alopecia in breast cancer patients ( Professors Hope Rugo, Debu Tripathy, Nadia Harbeck and Dr Steven Isakoff )
11 Dec 2018
Role of chemotherapy in the treatment of metastatic breast cancer patients
Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani
Role of chemotherapy in the treatment of metastatic breast cancer patients ( Professors Joseph Gligorov, Yen-Shen Lu, Chris Twelves and Dr Reshma Mahtani )
10 Dec 2018
Recent data on eribulin in metastatic breast cancer patients from SABCS 2018
Professor Chris Twelves and Dr Giampaolo Bianchini
Recent data on eribulin in metastatic breast cancer patients from SABCS 2018 ( Professor Chris Twelves and Dr Giampaolo Bianchini )
10 Dec 2018

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation